Systematic Literature Review of the Clinical Evidence in Relapsed/Refractory (R/R) Large B-Cell Lymphoma

被引：1
|
作者：
Maloney, David G. [1 ]
Liu, Fei Fei [2 ]
Nientker, Lisette [3 ]
Alleman, Cathelijne [3 ]
Hutton, Brian [4 ]
Garcia, Jacob [5 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[2] Celgene, Summit, NJ USA
[3] Pharmerit Int, Rotterdam, Netherlands
[4] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[5] Juno Therapeut Inc, Seattle, WA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127664
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5821
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The Burden of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Systematic Literature Review (SLR)
    Lenz, Georg
    Rutherford, Sarah C.
    Davies, Andrew
    Zinzani, Pier Luigi
    Salles, Gilles
    Hasskarl, Jens
    Margunato-Debay, Sandra
    Rodrigues, Filipe
    Nientker, Lisette
    Balradj, Janita
    Alleman, Cathelijne
    BLOOD, 2018, 132
  • [2] Clinical Efficacy and Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Literature Review
    Colosia, Ann
    Njue, Annete
    Trask, Peter C.
    Olivares, Robert
    Khan, Shahnaz
    Abbe, Adeline
    Police, Rachel
    Wang, Jianmin
    Ruiz-Soto, Rodrigo
    Kaye, James A.
    Awan, Farrukh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : 343 - 355
  • [3] Understanding the patient experience in follicular lymphoma (FL), relapsed/refractory FL (R/R FL), and relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)
    Bell, Jill A.
    Cherepanov, Dasha
    Revicki, Dennis
    Speck, Rebecca M.
    Swett, Laura
    Stumpo, Kate
    Rong, Yuanxin
    Gordon, Leo I.
    QUALITY OF LIFE RESEARCH, 2019, 28 : S67 - S68
  • [4] Total Cost of Care in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Gatwood, Justin
    Masaquel, Anthony
    Ross, Ryan
    Sheinson, Danny
    Hossain, Farah
    Li, Jia
    James, Cameron
    Fox, David
    BLOOD, 2022, 140 : 7906 - 7907
  • [5] CLINICAL PREDICTORS OF AXICABTAGENE CILOLEUCEL (AXI-CEL) THERAPY FOR RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL): A SYSTEMATIC LITERATURE REVIEW (SLR) AND META-ANALYSIS
    Sanderson, R.
    Munoz, J.
    Wang, Y.
    Kanters, S.
    Limbrick-Oldfield, E.
    Miao, H.
    Spooner, C.
    Baro, E.
    Xu, H.
    Jacobson, C.
    VALUE IN HEALTH, 2022, 25 (12) : S47 - S48
  • [6] Efficacy, Safety, and Patient-Reported Outcomes (PROs) of Treatments for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): A Systematic Literature Review (SLR)
    Ma, Qiufei
    Xu, Yingxin
    Srivastava, Rajni
    Kaushik, Namita
    Kaur, Mandeep
    Meng, Yang
    Quek, Ruben G. W.
    Mohamed, Hesham
    Ambati, Srikanth
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S396 - S396
  • [7] Clinical Pharmacology of CTL019 in Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)
    Awasthi, Rakesh
    Tam, Constantine S.
    Jaeger, Ulrich
    Jaglowski, Samantha
    Foley, Stephen Ronan
    Van Besien, Koen
    Wagner-Johnston, Nina D.
    Kersten, Marie Jose
    Schuster, Stephen J.
    Salles, Gilles Andre
    Maziarz, Richard Thomas
    Anak, Oezlem
    Pacaud, Lida Bubuteishvili
    Gazi, Lucien
    Waldron, Edward
    Hamilton, Jason
    Pruteanu, Iulian
    Tai, Feng
    Mueller, Karen Thudium
    Waller, Edmund K.
    BLOOD, 2017, 130
  • [8] Systematic Review of Therapy Used in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Galaznik, Aaron
    Bell, Jill A.
    Hoog, Meredith M.
    Stokes, Michael E.
    Steenrod, Anna W.
    Knopf, Kevin B.
    Seal, Brian
    Shou, Yaping
    BLOOD, 2016, 128 (22)
  • [9] Acalabrutinib monotherapy in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
    Dyer, Martin J. S.
    De Vos, Sven
    Ruan, Jia
    Flowers, Christopher
    Maddocks, Kami J.
    Rule, Simon
    Hamdy, Ahmed M.
    Izumi, Raquel
    Slatter, J. Greg
    Cheung, Jean
    Frigualt, Melanie M.
    Wei, Helen
    Mourya, Sanchita
    Hunder, Naomi N. H.
    Fowler, Nathan Hale
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Key Prognostic Factors in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: An Evidence Based Systematic Literature and Medical Review
    Von Tresckow, Bastian
    Costa, Pau Abrisqueta
    Aggarwal, Shivani
    Hampp, Christian
    Walsh, Laura
    Thorley, Eileen
    Shah, Mohsin
    Ma, Qiufei
    Ubieto, Ana Jimenez
    BLOOD, 2023, 142
12345